<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = "
Gilliad is in talks to expand the global supply of this drug, after it has obtained approval from the US Food and Drug Administration for its emergency use in treating Covid-19 patients..
Under the agreement, India’s “Jubilant” also obtains rights to manufacture the drug and increase its production.
“Gilead” said this month that it is negotiating to grant long-term licenses, with many drug makers in India and Pakistan, to produce Ramdesievir for the benefit of developing countries, and it will provide technology to assist production.
She added that the drug improved results for people with Covid-19, and provided data indicating that it works best when given in the early stages of infection..
“>
Gilliad is in talks to expand the global supply of this drug, after it has obtained approval from the US Food and Drug Administration for its emergency use in treating Covid-19 patients..
Under the agreement, India’s “Jubilant” also obtains rights to manufacture the drug and increase its production.
“Gilead” said this month that it is negotiating to grant long-term licenses, with many drug makers in India and Pakistan, to produce Ramdesievir for the benefit of developing countries, and it will provide technology to assist production.
She added that the drug improved results for people with Covid-19, and provided data indicating that it works best when given in the early stages of infection..
– .
